Log In
Print this Print this

Tenstaten, cicletanine

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension; Treat pulmonary arterial hypertension (PAH)
Regulatory Designation U.S. - Orphan Drug (Treat pulmonary arterial hypertension (PAH))
PartnerGilead Sciences Inc.;
Recordati S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today